Answers are grounded in this paper and cite their sources.
The new tool enhances DGM segmentation accuracy in multiple sclerosis, suggesting better neuroimaging outcomes.
Motivation: Publicly available T1-weighted-based segmentation tools may introduce systematic errors, especially in conditions like multiple sclerosis (MS), where atrophy is common. Goal(s): We aimed to improve segmentation accuracy by developing a multi-atlas, bi-parametric DGM tool (bi-parametric joint label fusion [B-JLF], leveraging QSM and T1-weighted images. Approach: We generated nine group-specific atlases across age and disease spectra, and modified the original ANTs JLF for multi-contrast based segmentation. We compared our tool against T1-based methods using overlap and susceptibility measures against manual segmentations. Results: B-JLF achieved superior voxel overlap (75%) and highest correlation with ground truth susceptibility (R²=0.88), outperforming T1-based methods. Impact: B-JLF provides reliable DGM segmentation, enhancing quantitative accuracy in neurodegenerative studies. The tool and atlases are publicly accessible, supporting broader neuroimaging applications.
No takes yet. Share an insight, caveat, or question.
Salman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: